SEO URLwww.firestrike.ai/deals/drugs-made-in-america-acquisition-corp-dld-asset-management-acquisition-2026
acquisitionAnnounced · Mar 9, 2026PharmaceuticalSource · CredibleArticle · Factual
DLD Asset Management acquires Drugs Made In America Acquisition Corp.
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$1.17M
Target
Drugs Made In America Acquisition Corp.
NASDAQ:DMAA
Acquirer
DLD Asset Management
Financial Stake
Status
Completed
DLD Asset Management agreed to acquire Drugs Made In America Acquisition Corp.. Reported deal value: $1.17M. Status: Completed. Sector: Pharmaceutical. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.
DLD Asset Management LP Decreases Position in Drugs Made In America Acquisition Corp . $DMAA
Deal timeline
Announced
Mar 9, 2026 · americanbankingnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceutical with a reported deal value of $1.17M. Figures and status may change as sources update.
Sources: americanbankingnews.com · Primary article · FireStrike proprietary index